Showing results (131-140 of 510) with videos related to

Sort By:
Pageof 51
Investigational New Drugs|March 1, 2018
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patientsTeresa Di Desidero, Paola Orlandi, Anna Fioravanti, et al.
BMC Cancer|July 10, 2020
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimensZev A Wainberg, Kynan Feeney, Myung Ah Lee, et al.
Pathologica|July 8, 2025
Lights and shadows of microsatellite status characterization in gastrointestinal cancers in the era of cancer precision therapyJessica Gasparello, Vittoria Matilde Piva, Valentina Angerilli, et al.
Drug Safety|January 17, 2019
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal MalignanciesLetizia Procaccio, Vera Damuzzo, Francesca Di Sarra, et al.
Expert Opinion on Biological Therapy|March 29, 2019
Ramucirumab: the long and winding road toward being an option for mCRC treatmentCeline Debeuckelaere, Sabina Murgioni, Sara Lonardi, et al.
Clinical Colorectal Cancer|October 20, 2019
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 AnalysesHeinz-Josef Lenz, Guillem Argiles, Takayuki Yoshino, et al.
Cancers|April 3, 2021
Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare ResourcesUmberto Cillo, Alessandro Vitale, Michael L Volk, et al.
Tumori|June 30, 2020
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysisMarco Mammana, Francesca Bergamo, Letizia Procaccio, et al.
Clinical Pharmacokinetics|August 14, 2025
Clinical Pharmacology Profile of the Claudin 18.2 Antibody ZolbetuximabJianning Yang, Akihiro Yamada, Kohei Shitara, et al.
International Journal of Molecular Sciences|March 27, 2025
Circulating Tumor DNA as a Real-Time Biomarker for Minimal Residual Disease and Recurrence Prediction in Stage II Colorectal Cancer: A Systematic Review and Meta-AnalysisSilvia Negro, Alessandra Pulvirenti, Chiara Trento, et al.
Pageof 51